1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Antigens, CD1d: new trials by email Literature Review of Antigens, CD1d trials Research Report on Antigens, CD1d
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML Injection - Non Small Cell Lung Cancer, Solid Tumor | Phase 2 | Unknown | Universitair Ziekenhuis Brussel | 36 | 2020-09-22 | 2022-09-14 |
Carcinoma, Non-Small-Cell Lung (1)
Universitair Ziekenhuis Brussel (1)
Belgium (1)